241 related articles for article (PubMed ID: 12243250)
21. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.
Aviram M; Kaplan M; Rosenblat M; Fuhrman B
Handb Exp Pharmacol; 2005; (170):263-300. PubMed ID: 16596803
[TBL] [Abstract][Full Text] [Related]
22. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement.
Upston JM; Terentis AC; Stocker R
FASEB J; 1999 Jun; 13(9):977-94. PubMed ID: 10336881
[TBL] [Abstract][Full Text] [Related]
23. Influence of natural antioxidants on in vitro lipoprotein oxidation.
Dobreanu M; Módy E
Rom J Intern Med; 1997; 35(1-4):55-62. PubMed ID: 9562653
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis?
Thomas SR; Neuzil J; Stocker R
Mol Aspects Med; 1997; 18 Suppl():S85-103. PubMed ID: 9266510
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein.
Chang YH; Abdalla DS; Sevanian A
Free Radic Biol Med; 1997; 23(2):202-14. PubMed ID: 9199882
[TBL] [Abstract][Full Text] [Related]
26. The oxidation hypothesis of atherosclerosis: an update.
Westhuyzen J
Ann Clin Lab Sci; 1997; 27(1):1-10. PubMed ID: 8997452
[TBL] [Abstract][Full Text] [Related]
27. Vitamin E supplementation of human macrophages prevents neither foam cell formation nor increased susceptibility of foam cells to lysis by oxidized LDL.
Asmis R; Jelk J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2078-86. PubMed ID: 10978252
[TBL] [Abstract][Full Text] [Related]
28. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits.
Tijburg LB; Wiseman SA; Meijer GW; Weststrate JA
Atherosclerosis; 1997 Nov; 135(1):37-47. PubMed ID: 9395271
[TBL] [Abstract][Full Text] [Related]
29. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation.
Hayek T; Fuhrman B; Vaya J; Rosenblat M; Belinky P; Coleman R; Elis A; Aviram M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2744-52. PubMed ID: 9409251
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
[TBL] [Abstract][Full Text] [Related]
31. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
Heinecke JW
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1261-4. PubMed ID: 11498450
[TBL] [Abstract][Full Text] [Related]
32. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
[TBL] [Abstract][Full Text] [Related]
33. [Oxidized lipoproteins and atherogenesis].
Jürgens G; Chen Q; Ledinski G; Kager G; Hammer A; Esterbauer H
Acta Med Austriaca; 1993; 20(4):85-9. PubMed ID: 8237282
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
[TBL] [Abstract][Full Text] [Related]
35. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
Torzewski M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
[TBL] [Abstract][Full Text] [Related]
36. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
Iuliano L; Pedersen JZ; Camastra C; Bello V; Ceccarelli S; Violi F
Free Radic Biol Med; 1999 Apr; 26(7-8):858-68. PubMed ID: 10232829
[TBL] [Abstract][Full Text] [Related]
37. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein.
Levy Y; Kaplan M; Ben-Amotz A; Aviram M
Isr J Med Sci; 1996 Jun; 32(6):473-8. PubMed ID: 8682654
[TBL] [Abstract][Full Text] [Related]
38. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
[TBL] [Abstract][Full Text] [Related]
39. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
40. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro.
Muna ZA; Doudin K; Songstad J; Ulvik RJ; Berge RK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3255-62. PubMed ID: 9409320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
